Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CWAN vs BRZE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CWAN Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 9–1 Matrix Metrics)

CWAN Overall Winner 6-Pillar Tally: CWAN 3 – 3 BRZE Matrix Metrics: CWAN 9 – 1 BRZE

As of Nov 20, 2026, Clearwater Analytics Holdings, Inc. (CWAN) is the stronger overall head-to-head candidate over Braze, Inc. (BRZE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CWAN carries a Unified Composite Score of 63.2/100 (BUY) at $24.56 (94.5x Forward P/E, 4.1% operating margin), whereas BRZE carries 35.6/100 (SELL) at $46.28 (72.8x Forward P/E, -11.9% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CWAN vs BRZE
CWAN NYSE Head-to-Head Winner
Clearwater Analytics Holdings, Inc.
Services-Prepackaged Software
$24.56
+0.04% 1D
Market Cap $7.3B
TTM Revenue $826M
Forward P/E 94.5x
Beta / 30D Vol 0.42β · 4% Vol
Unified Composite Score
63.2 / 100 BUY
Tech 75.0 Fund 62.0 Flow 69.0 Mom 29.5
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.3% over 20 days), RSI 68
RSI-14: 67.9 · SMA20: $24.38 · SMA50: $24.29
BRZE NASDAQ
Braze, Inc. Class A Common Stock
Services-Prepackaged Software
$46.28
+0.09% 1D
Market Cap $5.3B
TTM Revenue $834M
Forward P/E 72.8x
Beta / 30D Vol 0.56β · 5% Vol
Unified Composite Score
35.6 / 100 SELL
Tech 23.0 Fund 36.0 Flow 60.0 Mom 25.9
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (21.3% over 20 days), RSI 78
RSI-14: 78.1 · SMA20: $46.11 · SMA50: $35.88

6-Pillar Scorecard Institutional Category Breakdown (CWAN 3 – 3 BRZE)

Columns: Metric · CWAN · BRZE
1. Valuation Multiples BRZE
Forward P/E 94.5x 72.8x
Trailing P/E 35.6x 49.0x
PEG Ratio 1.78x 1.63x
EV / Revenue 8.9x 6.2x
2. Growth & Scale CWAN
Revenue Growth (YoY) +74.4% +26.2%
Earnings Growth (YoY) +202.8% +0.0%
TTM Revenue (USD) $826M $834M
Market Cap $7.3B $5.3B
3. Profitability & Quality CWAN
Gross Margin 66.0% 66.3%
Operating Margin 4.1% -11.9%
Net Profit Margin -5.8% -13.6%
Return on Equity (ROE) -3.1% -18.5%
4. Balance Sheet & Cash Flow CWAN
Cash Generation (TTM) $109M EBITDA $80M
Cash Flow Margin 13.2% EBITDA Mgn 9.6%
Net Cash / Leverage $6.89 Book/Sh · -3.1% ROE $70M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning BRZE
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile 0.8% (<1st %ile) 7.6% (3rd %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat BRZE
OpEx & R&D Intensity 61.9% of Rev ($511M) 78.2% of Rev ($652M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Application Operator Software - Application Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CWAN (9) vs BRZE (1)
Institutional Metric CWAN BRZE Criterion Row Edge
Market Capitalization
Scale
$7.3B $5.3B Larger Scale CWAN
Trailing P/E Ratio
Valuation
35.6x 49.0x Lower Multiple CWAN
Forward P/E Ratio
Valuation
94.5x 72.8x Lower Multiple BRZE
Revenue Growth (YoY)
Growth
+74.4% +26.2% Higher Growth CWAN
Operating Margin (TTM)
Profitability
4.1% -11.9% Higher Margin CWAN
Net Profit Margin
Profitability
-5.8% -13.6% Higher Margin CWAN
Return on Equity (ROE)
Capital Efficiency
-3.1% -18.5% Higher ROE CWAN
52-Week Range Position
Momentum
100% ($16–$25) 98% ($15–$47) Stronger Trend CWAN
Beta / 30D Volatility
Risk Regime
0.42β · 4% Vol 0.56β · 5% Vol Lower Realized Risk CWAN
Unified Institutional Score
Composite Signal
63.2 / 100 (BUY) 35.6 / 100 (SELL) Higher Composite CWAN
Trailing 12M Revenue (USD)
Operating Scale
$826M $834M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
66.0% 66.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.78x PEG · 8.9x EV/Rev 1.63x PEG · 6.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$109M EBITDA ($6.89 Book/Sh · -3.1% ROE) $80M ($70M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CWAN +20.99 pp
CWAN: +0.99% · BRZE: -20.0%
3M Horizon BRZE +2.19 pp
CWAN: +5.91% · BRZE: +8.1%
6M Horizon CWAN +54.98 pp
CWAN: +9.62% · BRZE: -45.36%
1Y Horizon CWAN +47.13 pp
CWAN: +18.7% · BRZE: -28.43%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CWAN vs BRZE. Trailing 12-month operating profitability (CWAN 4.1% vs BRZE -11.9%) and valuation multiples (CWAN 94.5x vs BRZE 72.8x Forward P/E) are benchmarked directly in Pillar 4 below.

CWAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$826M
Gross Margin66.0%
Op. Margin4.1%
ROE / Fwd P/E-3.1% · 94.5x
BRZE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$834M
Gross Margin66.3%
Op. Margin-11.9%
ROE / Fwd P/E-18.5% · 72.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CWAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 0.8%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact CWAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BRZE SURGE
5d in phase · OBV NEUTRAL
Current IV 7.6%
IV Percentile 3rd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact BRZE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CWAN Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $7.3B market capitalization and 4.1% operating margin.
OpEx & R&D Reinvestment 61.9% of Rev ($511M)
90D Engineering Disclosures 0 Published
BRZE Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $5.3B market capitalization and -11.9% operating margin.
OpEx & R&D Reinvestment 78.2% of Rev ($652M)
90D Engineering Disclosures 0 Published

Investor FAQ CWAN vs BRZE Key Questions & Quantitative Answers

As of Nov 20, 2026, Clearwater Analytics Holdings, Inc. (CWAN) is the stronger overall head-to-head candidate over Braze, Inc. (BRZE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CWAN carries a Unified Composite Score of 63.2/100 (BUY) at $24.56 (94.5x Forward P/E, 4.1% operating margin), whereas BRZE carries 35.6/100 (SELL) at $46.28 (72.8x Forward P/E, -11.9% operating margin). Technically, CWAN sits in a Markup phase (RSI 67.9, UNCLASSIFIED options structure) and BRZE sits in a Markup phase (RSI 78.1, SURGE options structure).

CWAN leads the Growth & Scale pillar: CWAN posts +74.4% YoY revenue growth and +202.8% YoY earnings growth on $826M TTM revenue (66.0% gross margin, 4.1% operating margin), compared with BRZE at +26.2% YoY revenue growth and +0.0% YoY earnings growth on $834M TTM revenue (66.3% gross margin, -11.9% operating margin). On trailing 12-month operating scale, CWAN generates $826M in USD-normalized revenue versus $834M for BRZE. In operating R&D and SG&A reinvestment, CWAN deploys 61.9% of Rev ($511M) (0 90-day corporate R&D disclosures) versus 78.2% of Rev ($652M) (0 disclosures) for BRZE.

BRZE screens cheaper on headline valuation multiples. CWAN trades at 94.5x Forward P/E, 35.6x Trailing P/E, 1.78x PEG, and 8.9x EV/Revenue (13.2% EBITDA margin), whereas BRZE trades at 72.8x Forward P/E, 49.0x Trailing P/E, 1.63x PEG, and 6.2x EV/Revenue (9.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CWAN (-3.1% ROE) versus BRZE (-18.5% ROE) capital efficiency.

In options market volatility and institutional positioning, CWAN carries 0.8% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.42β · 4% Vol realized risk). By comparison, BRZE carries 7.6% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.56β · 5% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.